FDA Inspection 1179131 — Laboratorio Genove SA

Laboratorio Genove SA — FEI 3003096558

The FDA completed an inspection of Laboratorio Genove SA on September 9, 2022 in Barcelona. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 9, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barcelona (Spain)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
117721 CFR 211.63Equipment Design, Size and Location
126321 CFR 211.68(b)Computer control of master formula records
136121 CFR 211.100(a)Absence of Written Procedures
360321 CFR 211.160(b)Scientifically sound laboratory controls
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.